Crossmark

Efficacy and safety of sequential therapy for primary osteoporosis with bone formation promoters followed by bone resorption inhibitors: a meta-analysis

Crossref DOI link: https://doi.org/10.1186/s13018-025-05545-1

Published Online: 2025-02-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Yuxin

Liu, Xin

Wu, Yuefeng

Luo, Tao
License Information

Text and Data Mining valid from 2025-02-07

Version of Record valid from 2025-02-07
More Information

Article History

Received: 25 December 2024

Accepted: 25 January 2025

First Online: 7 February 2025

Declarations

:

: Ethical review and approval were not required for the study on human participants in accordance with the local legislation and institutional requirements.

: All authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below